WR PHARMA LTD - Accounts

Registered Number: 13971334

England and Wales

Unaudited Financial Statements

for the year ended 31 March 2026

for

WR PHARMA LTD

WR PHARMA LTD

Statement of Financial Position

As at 31 March 2026

	£	2026 £	£	2025 £
Current assets	129,308		108,248
Creditors: amount falling due within one year	(72,884)		(67,857)
Net current assets/(liabilities)		56,424		40,391
Total assets less current liabilities		56,424		40,391
Accruals and deferred income		-		(2,159)
Net assets/(liabilities)		56,424		38,232


Capital and reserves		56,424		38,232

For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:

---------------------------------------------

Wasim Rafiq
Director

Date approved: 24 August 2026

WR PHARMA LTD

Notes to the Accounts

For the year ended 31 Mar 2026

Statutory Information

Wr Pharma Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 13971334, registration address 340 Blackburn Road, Accrington, BB5 1RZ, England.

The presentation currency is £ sterling.

1.	Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).

2.	Average number of employees Average number of employees during the year was 1 (2025: 1).